Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Will the US real estate housing market crash this year?

    February 5, 2023

    TikTok: Why were teddy bears invented?

    January 31, 2023

    People disgusted by the video of a Tasmanian couple caught in a physical act while trout fishing

    January 30, 2023
    Facebook Twitter Instagram
    Facebook Twitter Instagram Vimeo
    Hashtag Hyena
    Subscribe Login
    • Home
    • Instagram
      • Captions
      • Challenges
      • Filters
    • TikTok
      • Challenges
      • Dances
      • Filters
      • Recipes
      • Songs
    • Technology
      • Automobile
      • Gadgets
      • Mobiles
      • Robotics
    • Snapchat
      • Challenges
      • Filters
    • Business
      • Health
      • Drama
      • Featured
      • Interviews
    • Interior
      • Lifestyle
      • Politics
      • Memes
      • Relations
    • Travel
      • Slang
      • Sports
      • Twitter
      • YouTube
    Hashtag Hyena
    Home»Health»Tirzepatide: The most powerful weight loss drug is on the horizon
    Health

    Tirzepatide: The most powerful weight loss drug is on the horizon

    Devanshi MehtaBy Devanshi MehtaJanuary 4, 2023Updated:January 4, 2023No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Photo by Sasun Bughdaryan on Unsplash
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Tirzepatide, a promising weight loss drug, is expected to be approved by the FDA in 2023. Find out all about this treatment below.

    Experts are confident that the drug, called tirzepatide, will be granted approval by the FDA sometime next year. 
    If so, it would join two other popular, expensive, recently approved weight loss drugs on the market, Wegovy & Saxenda, both from the drugmaker Novo Nordisk.

    — Dr. Thomas Hoke -Phd. (@HokePhD) January 2, 2023

    About Trizepatide: The revolutionary weight loss drug that celebrities use

    Tirzepatide, an investigational drug developed by Eli Lilly, is expected to be approved by the Food and Drug Administration (FDA) for the treatment of obesity in 2023. The drug, which is administered by weekly injection, is already approved by the FDA under the name Mounjaro for the treatment of diabetes. In clinical trials, Tirzepatide has been shown to significantly reduce body weight and improve glycemic control in people with type 2 diabetes.

    See also  Viral illnesses could cause problems for people after the holidays

    Tirzepatide is a dual agonist of the GLP-1 and GIP hormones, which are involved in appetite control and glucose regulation. It has been shown to be more effective than other weight loss drugs, such as Wegovy and Saxenda, because it mimics two appetite-regulating hormones. In a clinical trial, participants who took a higher dosage of Tirzepatide lost up to 22.5% of their body weight, or about 52 pounds, over the course of 72 weeks.

    Now that #tirzepatide is hitting the mainstream, curious to see how many folks will indulge that have been pushing against trans kids using hormones. This is going to be interesting.

    — Vikki (@flowershark) January 1, 2023

    If approved for the treatment of obesity, Tirzepatide has the potential to achieve record annual sales of $48 billion, according to an estimate from Bank of America analyst Geoff Meacham. Another Wall Street analyst, Colin Bristow at UBS, estimated the drug would reach $25 billion in annual sales – a figure that would still surpass the record $20.7 billion set by AbbVie’s rheumatoid arthritis drug Humira in 2021.

    See also  TikTok: Creator Liver King promoting an “ancestral lifestyle” by eating raw testicles and liver

    While the potential for significant sales is attractive for Eli Lilly, it is unclear whether insurance will cover the use of Tirzepatide for the treatment of obesity. Lower doses used to treat diabetes are generally covered by insurance, but it is possible that higher doses used for weight loss may not be.

    The fact that diabetics still can’t get affordable prescriptions to begin with, & now people are trying to get their hands on tirzepatide, a diabetes medication, for weight loss w/ no regard for diabetics’ need for it is depraved

    — A (@alalliewhatever) January 1, 2023

    The cost of Tirzepatide for the treatment of obesity is also a concern. While Kelly Smith, a spokesperson for Eli Lilly, declined to comment on the price of the drug, outside experts have speculated that it could be priced similarly to Wegovy and Saxenda, which carry list prices of around $1,500 and $1,350 per month supply, respectively. Dr. David Rind, the Chief Medical Officer for the Institute for Clinical and Economic Review, estimates that a “fair” price for Tirzepatide could be around $13,000 annually or around $1,100 per month.

    See also  Tiktok: New Craze "Egg Cleanse" Technique Explained

    Tirzepatide has been shown to be effective in promoting weight loss, but it is important to note that it is not without drawbacks. The most common side effects of the drug are nausea, constipation, and diarrhea. It is also important to remember that Tirzepatide is not yet approved for use and further research is needed to determine its safety and effectiveness.

    Pin
    Tweet
    Share
    Share
    Drug Drugs health Weight Loss Weight management
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticlePrince Harry makes emotional plea for reconciliation with Royal Family in ITV interview
    Next Article TikTok: Everything you need to know about @Salah on TikTok
    Devanshi Mehta

      Chief Content Editor and Content Writer

      Related Posts

      A student death at UConn might have been due to medical issues

      January 29, 2023

      What does lemon water do to your body?

      January 19, 2023

      What does the mineral Zinc do for the body?

      January 19, 2023

      Middle school art teacher in New Jersey overdoses on Fentanyl in front of students

      January 14, 2023

      Comments are closed.

      Demo
      Our Picks
      • Facebook
      • Twitter
      • Pinterest
      • Instagram
      • YouTube
      • Vimeo
      Don't Miss
      Uncategorized

      Will the US real estate housing market crash this year?

      By AyeshaFebruary 5, 20230

      The real estate housing market is so weird that housing economists can not figure out…

      TikTok: Why were teddy bears invented?

      January 31, 2023

      People disgusted by the video of a Tasmanian couple caught in a physical act while trout fishing

      January 30, 2023

      TikTok: Do not miss out on @traveltmz on TikTok

      January 29, 2023

      Subscribe to Updates

      Get the latest creative news from SmartMag about art & design.

      About Us

      Your source for the lifestyle news. This demo is crafted specifically to exhibit the use of the theme as a lifestyle site. Visit our main page for more demos.

      We're accepting new partnerships right now.

      Email Us: info@example.com
      Contact: +1-320-0123-451

      Our Picks

      Actor Lance Kerwin’s cause of death remains unknown

      January 28, 2023

      The viral TikTok video of Bodega’s bro gets him fired

      July 2, 2022

      90 TikTok usernames for girls – funny, cute and sexy!

      May 31, 2022

      TikTok: Ancient forest discovered inside a giant sinkhole in China

      May 22, 2022
      New Comments
      • order paper online on Instagram: Is the password reset text from 32665 a scam?
      • paper writers for college on Instagram: 30 best Doja Cat lyrics for captions
      • paper writing website on What does ⭕️? mean on TikTok?
      • pay someone to do my paper on TikTok: Meaning of ‘Owa Owa’ explained – and who said it first!
      Facebook Twitter Instagram Pinterest
      • Home
      • ABOUT US
      • Business
      • Health
      • Instagram
      • Lifestyle
      • Contact us
      • Terms of Use
      • PRIVACY
      © copyright 2023 All rights reserved.

      Type above and press Enter to search. Press Esc to cancel.

      Sign In or Register

      Welcome Back!

      Login to your account below.

      For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

      I agree to these terms.

      Lost password?